Anti‐NT5C1A antibody positivitity was not associated with malignancy and interstitial lung disease, which are features important for patient management and prognosis in patients with dermatomyositis, antisynthetase syndrome, and IMNM. Here, NT5C1A is linked to dermatomyositis.